These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

290 related items for PubMed ID: 31267214

  • 1. Interobserver agreement of whole-body magnetic resonance imaging is superior to whole-body computed tomography for assessing disease burden in patients with multiple myeloma.
    Lai AYT, Riddell A, Barwick T, Boyd K, Rockall A, Kaiser M, Koh DM, Saffar H, Yusuf S, Messiou C.
    Eur Radiol; 2020 Jan; 30(1):320-327. PubMed ID: 31267214
    [Abstract] [Full Text] [Related]

  • 2. Assessing myeloma bone disease with whole-body diffusion-weighted imaging: comparison with x-ray skeletal survey by region and relationship with laboratory estimates of disease burden.
    Giles SL, deSouza NM, Collins DJ, Morgan VA, West S, Davies FE, Morgan GJ, Messiou C.
    Clin Radiol; 2015 Jun; 70(6):614-21. PubMed ID: 25799364
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Repeatability and test-retest reproducibility of mean apparent diffusion coefficient measurements of focal and diffuse disease in relapsed multiple myeloma at 3T whole body diffusion-weighted MRI (WB-DW-MRI).
    ElGendy K, Barwick TD, Auner HW, Chaidos A, Wallitt K, Sergot A, Rockall A.
    Br J Radiol; 2022 Sep 01; 95(1138):20220418. PubMed ID: 35867890
    [Abstract] [Full Text] [Related]

  • 5. Diagnostic value of whole body diffusion-weighted MRI compared to computed tomography for pre-operative assessment of patients suspected for ovarian cancer.
    Michielsen K, Dresen R, Vanslembrouck R, De Keyzer F, Amant F, Mussen E, Leunen K, Berteloot P, Moerman P, Vergote I, Vandecaveye V.
    Eur J Cancer; 2017 Sep 01; 83():88-98. PubMed ID: 28734146
    [Abstract] [Full Text] [Related]

  • 6. Comparison of Whole-Body DWI and 18F-FDG PET/CT for Detecting Intramedullary and Extramedullary Lesions in Multiple Myeloma.
    Chen J, Li C, Tian Y, Xiao Q, Deng M, Hu H, Wen B, He Y.
    AJR Am J Roentgenol; 2019 Sep 01; 213(3):514-523. PubMed ID: 31166755
    [Abstract] [Full Text] [Related]

  • 7. Prediction of Early Treatment Response in Multiple Myeloma Using MY-RADS Total Burden Score, ADC, and Fat Fraction From Whole-Body MRI: Impact of Anemia on Predictive Performance.
    Dong H, Huang W, Ji X, Huang L, Zou D, Hao M, Deng S, Shen Z, Lu X, Wang J, Song Z, Zhang X, Xue H, Xia S.
    AJR Am J Roentgenol; 2022 Feb 01; 218(2):310-319. PubMed ID: 34523949
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Sensitivity of whole-body CT and MRI versus projection radiography in the detection of osteolyses in patients with monoclonal plasma cell disease.
    Wolf MB, Murray F, Kilk K, Hillengass J, Delorme S, Heiss C, Neben K, Goldschmidt H, Kauczor HU, Weber MA.
    Eur J Radiol; 2014 Jul 01; 83(7):1222-1230. PubMed ID: 24793843
    [Abstract] [Full Text] [Related]

  • 10. Diagnostic performance of computed tomography and diffusion-weighted imaging as first-line imaging modality according to the International Myeloma Working Group (IMWG) imaging algorithm for monoclonal plasma cell disorders.
    Yoon MA, Chee CG, Chung HW, Lee DH, Kim KW.
    Acta Radiol; 2022 May 01; 63(5):672-683. PubMed ID: 33853375
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Whole-body MRI versus an FDG-PET/CT-based reference standard for staging of paediatric Hodgkin lymphoma: a prospective multicentre study.
    Spijkers S, Littooij AS, Kwee TC, Tolboom N, Beishuizen A, Bruin MCA, Elias SG, van de Brug T, Enríquez G, Sábado C, Miller E, Granata C, de Lange C, Verzegnassi F, Greer MC, de Keizer B, Nievelstein RAJ.
    Eur Radiol; 2021 Mar 01; 31(3):1494-1504. PubMed ID: 32880696
    [Abstract] [Full Text] [Related]

  • 13. Whole-body-MR imaging including DWIBS in the work-up of patients with head and neck squamous cell carcinoma: a feasibility study.
    Noij DP, Boerhout EJ, Pieters-van den Bos IC, Comans EF, Oprea-Lager D, Reinhard R, Hoekstra OS, de Bree R, de Graaf P, Castelijns JA.
    Eur J Radiol; 2014 Jul 01; 83(7):1144-1151. PubMed ID: 24768188
    [Abstract] [Full Text] [Related]

  • 14. Quantification of tumor burden in multiple myeloma by atlas-based semi-automatic segmentation of WB-DWI.
    Almeida SD, Santinha J, Oliveira FPM, Ip J, Lisitskaya M, Lourenço J, Uysal A, Matos C, João C, Papanikolaou N.
    Cancer Imaging; 2020 Jan 13; 20(1):6. PubMed ID: 31931880
    [Abstract] [Full Text] [Related]

  • 15. Inter-observer agreement of baseline whole body MRI in multiple myeloma.
    Croft J, Riddell A, Koh DM, Downey K, Blackledge M, Usher M, Boyd K, Kaiser M, Messiou C.
    Cancer Imaging; 2020 Jul 14; 20(1):48. PubMed ID: 32665028
    [Abstract] [Full Text] [Related]

  • 16. Newly diagnosed lymphoma: initial results with whole-body T1-weighted, STIR, and diffusion-weighted MRI compared with 18F-FDG PET/CT.
    van Ufford HM, Kwee TC, Beek FJ, van Leeuwen MS, Takahara T, Fijnheer R, Nievelstein RA, de Klerk JM.
    AJR Am J Roentgenol; 2011 Mar 14; 196(3):662-9. PubMed ID: 21343511
    [Abstract] [Full Text] [Related]

  • 17. Whole-body low-dose CT recognizes two distinct patterns of lytic lesions in multiple myeloma patients with different disease metabolism at PET/MRI.
    Zambello R, Crimì F, Lico A, Barilà G, Branca A, Guolo A, Varin C, Vezzaro R, Checuz L, Scapin V, Berno T, Pizzi M, Ponzoni A, De Biasi E, Vio S, Semenzato G, Zucchetta P, Lacognata C.
    Ann Hematol; 2019 Mar 14; 98(3):679-689. PubMed ID: 30539276
    [Abstract] [Full Text] [Related]

  • 18. Current concepts in tumor imaging with whole-body MRI with diffusion imaging (WB-MRI-DWI) in multiple myeloma and lymphoma.
    Stecco A, Buemi F, Iannessi A, Carriero A, Gallamini A.
    Leuk Lymphoma; 2018 Nov 14; 59(11):2546-2556. PubMed ID: 29431555
    [Abstract] [Full Text] [Related]

  • 19. A survey study investigating perceptions and acceptance of the whole-body imaging techniques used for the diagnosis of myeloma.
    Ryder A, Parsons C, Hutchinson CE, Greaney B, Thake CD.
    Radiography (Lond); 2021 Nov 14; 27(4):1149-1157. PubMed ID: 34257014
    [Abstract] [Full Text] [Related]

  • 20. 18F-FDG PET/CT and whole-body MRI diagnostic performance in M staging for non-small cell lung cancer: a systematic review and meta-analysis.
    Machado Medeiros T, Altmayer S, Watte G, Zanon M, Basso Dias A, Henz Concatto N, Hoefel Paes J, Mattiello R, de Souza Santos F, Mohammed TL, Verma N, Hochhegger B.
    Eur Radiol; 2020 Jul 14; 30(7):3641-3649. PubMed ID: 32125513
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.